Literature DB >> 17082006

Translational efficiency in patients with Diamond-Blackfan anemia.

Jana Cmejlova1, Ludmila Dolezalova, Dagmar Pospisilova, Kvetoslava Petrtylova, Jiri Petrak, Radek Cmejla.   

Abstract

BACKGROUND AND OBJECTIVES: Diamond-Blackfan anemia (DBA) is a rare congenital pure red cell aplasia characterized by normochromic macrocytic anemia, reticulocytopenia, and normocellular bone marrow with a selective deficiency of erythroid precursors. Ribosomal protein S19 (RPS19), currently the only gene associated with DBA, is mutated in 25% of DBA patients, but its role in erythropoiesis is unknown. We attempted to elucidate the importance of RPS19 in translation in relation to the pathogenesis of DBA. DESIGN AND METHODS: We measured translation and proliferation rates in unstimulated and phytohemagglutinin (PHA)-stimulated lymphocytes isolated from DBA patients, as well as in K562 cells expressing several RPS19 mutants to directly test the effect of RPS19 mutations on translation. The effect of leucine on overall translation was also studied.
RESULTS: We found that the level of translation was on average 48-73% of controls in both unstimulated and PHA-activated DBA lymphocytes irrespective of mutations in RPS19. The addition of leucine increased the translational level in RPS19-non-mutated DBA cells, but not in cells with an RPS19 mutation. In unstimulated DBA cells, proliferation was significantly impaired in both RPS19-mutated and non-mutated cells, but in both groups could be efficiently activated by PHA. Studies on K562 cells showed that RPS19 mutations affecting RPS19 conserved arginines R56Q and R62Q could significantly inhibit the rate of protein synthesis, indicating the importance of RPS19 in translation. INTERPRETATION AND
CONCLUSIONS: Our results indicate that inefficient translation may be the main cause of DBA, and administration of leucine may be beneficial for at least some DBA patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082006

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  33 in total

Review 1.  Ribosomopathies: human disorders of ribosome dysfunction.

Authors:  Anupama Narla; Benjamin L Ebert
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

2.  L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.

Authors:  Elspeth M Payne; Maria Virgilio; Anupama Narla; Hong Sun; Michelle Levine; Barry H Paw; Nancy Berliner; A Thomas Look; Benjamin L Ebert; Arati Khanna-Gupta
Journal:  Blood       Date:  2012-06-25       Impact factor: 22.113

3.  Reduced translation of GATA1 in Diamond-Blackfan anemia.

Authors:  Jacqueline Boultwood; Andrea Pellagatti
Journal:  Nat Med       Date:  2014-07       Impact factor: 53.440

Review 4.  Marrow failure: a window into ribosome biology.

Authors:  Davide Ruggero; Akiko Shimamura
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

5.  Bmi1 promotes erythroid development through regulating ribosome biogenesis.

Authors:  Rui Gao; Sisi Chen; Michihiro Kobayashi; Hao Yu; Yingchi Zhang; Yang Wan; Sara K Young; Anthony Soltis; Ming Yu; Sasidhar Vemula; Ernest Fraenkel; Alan Cantor; Yevgeniy Antipin; Yang Xu; Mervin C Yoder; Ronald C Wek; Steven R Ellis; Reuben Kapur; Xiaofan Zhu; Yan Liu
Journal:  Stem Cells       Date:  2015-03       Impact factor: 6.277

6.  The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA.

Authors:  Karthik A Ganapathi; Karyn M Austin; Chung-Sheng Lee; Anusha Dias; Maggie M Malsch; Robin Reed; Akiko Shimamura
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

7.  A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition.

Authors:  Chang-Hyun Lee; Marianthi Kiparaki; Jorge Blanco; Virginia Folgado; Zhejun Ji; Amit Kumar; Gerard Rimesso; Nicholas E Baker
Journal:  Dev Cell       Date:  2018-08-02       Impact factor: 12.270

8.  Posttranscriptional down-regulation of small ribosomal subunit proteins correlates with reduction of 18S rRNA in RPS19 deficiency.

Authors:  Jitendra Badhai; Anne-Sophie Fröjmark; Hamid Reza Razzaghian; Edward Davey; Jens Schuster; Niklas Dahl
Journal:  FEBS Lett       Date:  2009-05-18       Impact factor: 4.124

9.  Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia.

Authors:  Jason E Farrar; Michelle Nater; Emi Caywood; Michael A McDevitt; Jeanne Kowalski; Clifford M Takemoto; C Conover Talbot; Paul Meltzer; Diane Esposito; Alan H Beggs; Hal E Schneider; Agnieszka Grabowska; Sarah E Ball; Edyta Niewiadomska; Colin A Sieff; Adrianna Vlachos; Eva Atsidaftos; Steven R Ellis; Jeffrey M Lipton; Hanna T Gazda; Robert J Arceci
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

10.  Fibroblasts from patients with Diamond-Blackfan anaemia show abnormal expression of genes involved in protein synthesis, amino acid metabolism and cancer.

Authors:  Federica Avondo; Paola Roncaglia; Nicoletta Crescenzio; Helena Krmac; Emanuela Garelli; Marta Armiraglio; Carlotta Castagnoli; Maria Francesca Campagnoli; Ugo Ramenghi; Stefano Gustincich; Claudio Santoro; Irma Dianzani
Journal:  BMC Genomics       Date:  2009-09-18       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.